Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common: 2020-2024

Historic Dividends Paid - Common for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $494,000.

  • Maravai Lifesciences Holdings' Dividends Paid - Common was N/A to -$78,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $10.1 million, marking a year-over-year change of. This contributed to the annual value of $494,000 for FY2024, which is 94.86% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Dividends Paid - Common of $494,000 as of FY2024, which was down 94.86% from $9.6 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common ranged from a high of $153.5 million in FY2021 and a low of $494,000 during FY2024.
  • Moreover, its 3-year median value for Dividends Paid - Common was $9.6 million (2023), whereas its average is $53.4 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common increased by 27.87% in 2021 and then tumbled by 94.86% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common (Yearly) stood at $120.0 million in 2020, then increased by 27.87% to $153.5 million in 2021, then dropped by 2.11% to $150.2 million in 2022, then plummeted by 93.60% to $9.6 million in 2023, then slumped by 94.86% to $494,000 in 2024.